Italia markets closed

TEVA Jun 2024 16.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0300-0,0100 (-25,00%)
In data: 10:37AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,0400
Aperto0,0500
Denaro0,0000
Domanda0,0100
Prezzo d'esercizio16,50
Scadenza2024-06-28
Min-Max giorno0,0300 - 0,0500
Contratto - Min-MaxN/D
Volume435
Open Interest1,75k
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.